Skip to content

H.R. 1396 · 119th Congress (2025–2027)

PILLS Act

To amend the Internal Revenue Code of 1986 to establish the generic drugs and biosimilars production credit, and for other purposes.

CRS summary not yet available.

Referred to committee

Latest actionReferred to committee

This bill’s path

This is H.R. 1396’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced

  2. Passed House

  3. Passed Senate

  4. Sent to President

  5. Signed into law

Sponsor
Rep. Claudia Tenney (R-NY-24)
Cosponsors
2 cosponsors

0 original · 2 later

  1. Rep. Nicole Malliotakis (R-NY-11)· Later · Sep 26, 2025
  2. Rep. W. Gregory Steube (R-FL-17)· Later · Nov 20, 2025
Policy area
Taxation

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Introduced in House

    Document: Introduced in House

    Sources
  2. Latest

    Referred to committee

    Referred to the House Committee on Ways and Means.

    Sources

Committees

  1. HouseWays and MeansReferred Feb 14, 2025

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in House
Titles (3)
  1. PILLS Act

    Display title, Short title · Introduced in House

  2. Producing Incentives for Long-term production of Lifesaving Supply of medicine Act

    Short title · Introduced in House

  3. To amend the Internal Revenue Code of 1986 to establish the generic drugs and biosimilars production credit, and for other purposes.

    Official title · Introduced in House